Finance

Lists
Why is OKYO up 3.60%?
Dive Deeper
OKYO:NASDAQ
OKYO Pharma Ltd
$1.44
+3.60%
(+0.050) 1D
Oct 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKYO...
Open
$1.40
High
$1.53
Low
$1.35
Mkt. cap
75.57M
Avg. vol.
74.36K
Volume
115.55K
52-wk high
$3.20
52-wk low
$1.26
EPS
-$0.32
Beta
-0.03
Shares outstanding
52.48M
No. of employees
5
Open
$1.40
High
$1.53
Low
$1.35
Mkt. cap
75.57M
Avg. vol.
74.36K
Volume
115.55K
52-wk high
$3.20
52-wk low
$1.26
EPS
-$0.32
Beta
-0.03
Shares outstanding
52.48M
No. of employees
5
News stories
From web sources and news partners
About OKYO Pharma Ltd
CEO-
Employees5
Founded2007
Headquarters-
SectorBiotechnology
Websiteokyopharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to OKYO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OKYO in the last 3 months.
Highest
Current $1.44
$7.00 (+386.11%)
Average
$6.00 (+316.67%)
Lowest
$5.00 (+247.22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$5.00
+247.2%
10/06/2026
Biren Amin
Piper Sandler
Buy
Maintained
$7.00
+386.1%
08/27/2026
William Wood
B. Riley Securities
Buy
Initiated
$5.00
+247.2%
12/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
1.27M
1.27M
2.07M
2.07M
Cost of revenue
1.27M
1.27M
2.07M
2.07M
Research and development expenses
-22.02K
-22.02K
926.55K
926.55K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-22.02K
-22.02K
926.55K
926.55K
Total operating expenses
1.25M
1.25M
3.00M
3.00M
Operating income
-1.25M
-1.25M
-3.00M
-3.00M
Other non operating income
-
-
-140.00
-140.00
EBT including unusual items
-1.29M
-1.29M
-3.18M
-3.18M
EBT excluding unusual items
-1.29M
-1.29M
-3.18M
-3.18M
Income tax expense
26.00
26.00
3.97K
3.97K
Effective tax rate
-
-
-0.12%
-0.12%
Other operating expenses
-
-
-
-
Net income
-1.29M
-1.29M
-3.18M
-3.18M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
16.05K
16.05K
Interest expense
-42.29K
-42.29K
-194.68K
-194.68K
Net interest expenses
-42.29K
-42.29K
-178.63K
-178.63K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.25M
-1.25M
-3.00M
-3.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps